US Edition
Rewriting the Future of Hunter Syndrome: Innovation Challenges the One-Drug Legacy in MPS II
Summary by kalkinemedia.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
All
Left
Center
Right
International conference dedicated to innovations in the treatment of rare and incurable diseases held
The Urgent Need for Innovation in Orphan Disease Drug Development
Orphan drugs are the essential drugs that cure rare diseases, but they still lack proper treatment plans and financial initiatives to support further drug development. A large section of people in Europe and the United States have been impacted by orphan diseases, and there are approximately 5000 to 8000 orphan diseases that affect 50 million people in these regions. So, the new initiatives are taken into consideration for rare and orphan diseas…
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium